Clinical trial Recruiting at 1 site Interventional Ages 16 and up

Impact of Nasogastric Tube on Nausea and Vomiting After Jaw Surgery

Official title: The Impact of Nasogastric Tube Gastric Decompression on Postoperative Nausea and Vomiting in Orthognathic Surgery

Run by Nova Scotia Health Authority · NCT06422793 · Data updated 2026-11-12

This study is testing if using a nasogastric tube after jaw surgery can help reduce nausea and vomiting in patients during the first day after their operation.

More Postoperative Nausea and Vomiting trials

Quick facts

Study typeInterventional
Ages16 Years and up
SexAll
Enrollment92 (estimated)
SponsorNova Scotia Health Authority
Academic / other
Locations1 site (Halifax, Nova Scotia)
StatusRecruiting
StartedDecember 4, 2024
Main results expectedJuly 2025
Study endsDecember 2025
Registry record updatedJanuary 14, 2025
Trial IDNCT06422793 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients over 16 years old undergoing orthognathic surgery for dentofacial deformities at Victoria General Hospital.

Probably not a fit

Patients under 16, those contraindicated for elective surgery, or those with specific risk factors for PONV may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the occurrence of postoperative nausea and vomiting (PONV) in patients undergoing orthognathic surgery with and without the use of nasogastric tube gastric decompression. It aims to determine if gastric decompression can reduce the incidence of PONV in the first 24 hours post-surgery. Participants will be randomly assigned to either receive an NG tube for gastric decompression or not, with monitoring for PONV and other influencing factors such as anesthesia type and surgery duration. The study is conducted at Victoria General Hospital in Halifax, Nova Scotia.

Why it matters

Potential benefit: If successful, this study could lead to improved management of postoperative nausea and vomiting in patients undergoing orthognathic surgery.

How similar studies have gone: Other studies have explored the use of nasogastric tubes for PONV management, but this specific approach in orthognathic surgery is less commonly tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients over the age of 16 at the time of consent undergoing orthognathic surgery for the correction of dentofacial deformities at the Victoria General Hospital during the study period.

Orthognathic surgery to include:

1. Patients who receive single-jaw surgery (i.e. BSSO \[Bilateral Sagittal Split Osteotomy\] only, or LeFort only).
2. Patients receiving double-jaw surgery (i.e. BSSO and LeFort).
3. Patients undergoing a functional genioplasty in addition to another osteotomy (i.e. BSSO and/or LeFort).

Exclusion Criteria:

* Patients will be excluded if they do not meet inclusion criteria or if they have risk factors known to directly impact PONV and/or cause delayed gastric emptying:

  1. Patients under the age of 16 at the time of consent.
  2. Patients contraindicated to undergo elective surgery, including pregnant patients.
  3. Patients undergoing a functional genioplasty procedure only.
  4. Patients taking GLP-1 receptor agonists).
  5. Patients with known gastroparesis.

Where it's running

  • Victoria General Hospital
    Halifax, Nova Scotia, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.